Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login
Featured / In the News / Politics

FDA-Approved Afrezza: An Inhal...

By: Elissa Tam, PharmD Candidate c/o 2015 – Patients with Type 1 or Type 2 diabetes who cannot control their glucose levels simply by taking oral medications have to inject insulin daily. They also have to measure their glucose levels by using strips and lancets on a regular basis. For patients, especially elderly ones, the…

Featured / In the News / Politics

Combating Counterfeit Drugs...

By: Azia Tariq, Staff Editor – With the sale of counterfeit drugs reaching an alarmingly higher rate than ever, The U.S Food and Drug Administration (FDA) in collaboration with the Skoll Global Threats Fund, the U.S. Pharmacopeia (USP), the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the multi-agency…

Featured / Professional Advice / Opinions

An Interview with an FDA Prece...

By: Melissa Roy Co-Copy Editor [Graphics focused] – Our dedicated preceptor Kimberly Defronzo, RPh, MS, MBA is currently a Consumer Safety Officer at the Food and Drug Administration (FDA). She attended the University of Connecticut School of Pharmacy for her Bachelors of Pharmacy. She then went to St. John’s University College of Pharmacy and Health…

Featured / In the News / Politics

In Wine There Is Truth...

By: Katharine Cimmino, Editor-in-Chief – Many articles and quick one-line stories have been cropping up on the internet boasting the benefits of drinking wine regularly.  While headlines such as, “Drinking a Glass of Red Wine is the same as Getting an Hour of Exercise, Says New Study,” may make readers ecstatic that their drinking habits…

Clinical / Featured

HIV Pre-Exposure Prophylaxis...

By: Elissa Tam PharmD Candidate c/o 2015 – HIV/AIDS continues to be a persistent problem in the United States and in various countries around the world. In 2010 alone, there were around 47,500 new HIV infections in the United States with about 1.1 million Americans living with HIV at the end of 2010.1 When left…

Events / Featured

St. John’s Pharmacy Students...

By: Kenny Ng, STJ AMCP Chapter President, PharmD c/o 2017, Kenny Chan, STJ AMCP Chapter President-Elect, PharmD c/o 2017, Davidta Brown, Senior Staff Editor – While those who work tirelessly to combat the spread of Hepatitis B and C never have a day off, there is one day in the year during which special attention…

Featured / In the News / Politics

Ebola Outbreak in West Africa...

By: Azia Tariq, Staff Editor – The first recorded outbreak of the Ebola Zaire (ZEBOV), a strain of the ebola virus, occurred in 1976. Since then, three additional types of the deadly virus have been discovered: Sudan Ebola virus (SEBOV), Reston Ebola virus (REBOV), and Côte d’Ivoire Ebola virus (CIEBOV).1 The initial outbreak had, until…

Featured / In the News / Politics

Celiac Disease: Seeking Proper...

By: Sang Hyo Kim, Staff Editor – The Mayo Clinic reported in the American Journal of Gastroenterology that 1.8 million people in the United States suffer from celiac disease.1 More notably, of this population, over 75% of people are unaware that they even have this condition. While other studies have been conducted to determine the…

Clinical / Featured

Reservoir of Migraine Therapie...

By Davidta Brown, Senior Staff Editor – The pain, nausea, and light or sound sensitivity that comprise a migraine attack afflict more than 10% of individuals around the world, easily making migraines one of the most globally debilitating diseases of the present day.1 According to the International Headache Society (IHS), migraines are defined by both…

Clinical / Featured

Pediatric Hypertension...

By: Anthony Botte and Tyler Valente, PharmD Candidates c/o 2016 – Diseases which are prevalent within the pediatric population require distinct protocols for treatment accompanied by the utmost care and precision. Pediatric hypertension (HTN) is one disease state in particular that has come to the forefront of medical practice in the United States over the…

Featured / Professional Advice / Opinions

Drug Shortages: Effects &...

By: Valentina DiGangi,PharmD Candidate c/o 2017, Brandon Hu, PharmD Candidate c/o 2018, Sang Hyo Kim, Staff Editor, Samantha Lau, PharmD Candidate c/o 2018, and Seowoo Yoon, PharmD Candidate c/o 2018 – What does a clinician do when there is limited access to a particular drug, such as morphine? Should they treat a patient who is…

Featured / In the News / Politics

The Role of Pharmacists Expand...

By: Sherin Pathickal, PharmD Candidate c/o 2016 – In 2006, the Institute of Medicine reported that over 1.5 million people in the US suffered from a medication error, errors that not only cost the economy billions of dollars, but endangered countless lives.1 Each year, approximately 7,000 deaths occur to due to preventable medication related errors.2…

Featured / In the News / Politics

Migraine Relief at the Push of...

By: Davidta Brown, Senior Staff Editor – A new therapeutic device has seemingly leapt from the pages of a science fiction novel and into the hands of migraine sufferers around the world. Worn over the forehead and sending electromagnetic stimulation directly into the supraorbital trigeminal nerves, the cranial nerve stimulator offered by Belgian biotechnology company…

Featured / In the News / Politics

Tailored Tablets...

By: Azia Tariq, Staff Editor – Truly personalized medication is the goal of researchers in the pharmaceutical and biotechnological industries. For example, when a patient requires a precise dose that is not manufactured as a tablet, the tablet will be broken up in order to deliver the dose as close as possible. Not only is…

Featured / Professional Advice / Opinions

Quantifying the Benefits of Ph...

By Davidta Brown, Senior Staff Editor – The idea of granting pharmacists the right to prescribe, as well as to counsel and dispense, has long been a source of controversy among healthcare professionals. A study out of the University of Alberta in Canada, published online in mid-April, provided some much needed concrete data for an…

Clinical / Featured

Recent Advances in HIV Treatme...

By: Jenny Park PharmD Candidate c/o 2015 – A series of broad HIV specific monoclonal antibodies (mAb) have been isolated and been shown to bind to CD4 binding sites, V1/V2 loops, V3/V4 loops, glycans, and proximal external regions. It has been shown that administration of a “cocktail” of HIV-1 specific monoclonal antibodies along with single…

Featured / In the News / Politics

Grastek®: FDA Approves New Su...

By: Kevin Lin, PharmD Candidate c/o 2015 – This April, the FDA approved three sublingual immunotherapies for pollen induced allergic rhinitis: Grastek® (Timothy Grass Pollen Allergen Extract), Oralair® (Grass Pollen Allergen Extract), and Ragwitek® (Short Ragweed Pollen Allergen Extract). Formulated by Merck, Grastek® is Timothy grass pollen allergen extract. It is approved for patients ages…

Featured / In the News / Politics

The Importance of the Measles ...

By: Sherin Pathickal, PharmD Candidate c/o 2016 – The mandatory receipt of vaccinations as a preventive public health measure has long been a controversial issue in our society.1 Despite the popular use of immunizations, many reservations about vaccine constituents and their safety have prevailed, leading to increasing numbers of unvaccinated people.1 Opponents of vaccinations have…

Clinical / Featured

Antipsychotic Use in the Elder...

By: Ada Seldin, Staff Editor – The overuse of antipsychotics in the nursing home population for off-label indications continues to impact patient safety. In 2005, the FDA issued a black box warning that stated, “The treatment of behavioral disorders in elderly patients with dementia with atypical antipsychotic medications is associated with increased mortality.” The evidence…

Clinical / Featured

The Dangers of Intrathecal Bac...

By: Ada Seldin, Staff Editor – Intrathecal baclofen (ITB) is indicated for the treatment of intractable spasticity caused by spinal cord injury, multiple sclerosis, spinal ischemia or tumor, transverse myelitis, cervical spondylosis, cerebral palsy, and degenerative myelopathy.1 Baclofen inhibits both monosynaptic and polysynaptic reflexes at the spinal cord level by decreasing excitatory neurotransmitter release from…

Featured / In the News / Politics

New Considerations for Testost...

By: Jenny Park PharmD Candidate c/o 2015 – Testosterone is a hormone essential to male development. However, treatment of testosterone deficiency is FDA approved only when accompanied with another medical condition such as failure of testicles to produce testosterone due to chemotherapy or even genetic conditions.1 In 2011, 5.3 million prescriptions for testosterone were written…

Featured / Professional Advice / Opinions

I Have a Problem...

By: Sang Hyub Kim, DPM Candidate c/o 2018, New York College of Podiatric Medicine – I was diagnosed with ulcerative colitis in 2009. For the past five years, I have literally taken tons of immunosuppressant medications, ranging from corticosteroids (prednisone), to chemotherapeutics (6-Mercaptopurine) in an effort to suppress the inflammation in my colon. Currently, I…

Featured / In the News / Politics

Scientists Finally Discover Ho...

By: Sabrina Ahmed, PharmD Candidate c/o 2017 – Over the decades, one of the biggest mysteries encountered by researchers has been why so many CD4 T-cells die when one is infected with Human Immunodeficiency Virus (HIV).1 CD4 T-cells are an integral part of the immune system as they locate pathogens and signal other immune cells…

Featured / In the News / Politics

Evzio™ – New Naloxone Auto...

By: Diana Gritsenko, PharmD Candidate c/o 2015 – Drug overdose is a serious problem in the United States.  In 2010, drug overdose caused more deaths among adults within the ages of 25 and 64 years than motor vehicle accidents. The Center for Disease Control (CDC), ran an analysis that showed drug overdose death rates have…

Featured / In the News / Politics

FDA Approves Drug Elosulfase A...

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  – On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy for Morquio A Syndrome, a type of mucopolysaccharidosis (MPS IVA).1 Elosulfase alfa was granted priority review and was also the first drug to receive the Rare Pediatric Disease Priority Review Voucher that motivates the development…

Featured / In the News / Politics

Possible New Prostate Cancer S...

By: Fatema Elias, Senior Staff Editor – Prostate cancer occurs when abnormal cells form in the tissues of the prostate gland. It often develops in men over the age of 50, and the numbers of estimated new cases and of deaths from prostate cancer in the United States in 2013 are 238,590 and 29,720, respectively.1…

Events / Featured

Rho Chi Society’s 90th Annua...

By: Fawad Piracha, PharmD Candidate c/o 2016 – Rho Chi Society held its 90th annual meeting on Sunday, March 30, 2014 at the Hyatt Regency Orlando, paralleling the American Pharmacists Association (APhA) 2014 Annual Meeting and Exposition that took place the same weekend. In attendance were delegates and advisors of Rho Chi chapters from pharmacy…

Clinical / Featured

The Use of Topical Opioid Trea...

By: Katharine Cimmino, Editor-in-Chief – Pressure ulcers can be a painful condition decreasing the quality of life of patients and prolonging hospital stays.1 About 10% of hospital inpatients and 26% of hospice admissions have pressure sores.2 Pressure ulcers are injuries that occur when pressure is applied for prolonged periods of time over bony prominences.1 There…

Events / Featured

Brown-Bag Event...

By: Hayeon Na, Co-Copy Editor (Content Focused) – On February 26th, 2014, pharmacists, clinical faculty, and pharmacy students from St. John’s University College of Pharmacy and Health Sciences gathered at the Freeport Memorial Library for a “Brown Bag,” one of the yearly calendar events at the public library. This event was conducted through the joint…

Featured / In the News / Politics

New Strides in Lupus Treatment...

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 – Systemic lupus erythematosus (SLE) is a debilitating autoimmune disease that affects multiple organs in the body and can potentially become life threatening.1 The incidence of SLE is about 50 cases for every 100,000 people; it…

Clinical / Featured

Riociguat (Adempas®) New Dru...

By: Hayeon Na, Co-Copy Editor [Content-Focused] – On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for the treatment of patients whose pulmonary hypertension (PH) belongs in WHO groups 1 and 4.1 Riociguat (Adempas®) is a soluble guanylate cyclase (sGC) stimulator, and currently the only one of its kind on the market.…

Featured / In the News / Politics

The Surgeon General’s 2014 R...

By: Ada Seldin, Staff Editor – Since the first release of the Surgeon General’s Report on smoking 50 years ago, it has become clear that smoking results in premature death and a myriad of diseases, affecting almost every organ system. Public health initiatives to increase awareness, prevent initiation, and promote smoking cessation have been marginally…

Featured / In the News / Politics

Tasimelteon (Hetlioz®): Firs...

By: Beatrisa Popovitz, Senior Staff Editor – On January 31st 2014, the FDA announced the release of a revolutionary new drug, tasimelteon (Hetlioz®). Tasimeleton is the first developed treatment of non-24-hour sleep-wake cycle syndrome in blind individuals.1 Formulated by Vanda Pharmaceuticals Inc., this melatonin receptor agonist works by binding to and activating the MT1 and…

Featured / In the News / Politics

New Legislation Redefines Over...

By: Davidta Brown, Senior Staff Editor – As the world of healthcare and its provision evolves, laws which organize and oversee the ways that patients receive health services must develop at the same pace. Last November, a new bill establishing clearer protocol for the compounding and tracking of medications became national law. The Drug Quality…

Featured / In the News / Politics

Prior Experience and the Growt...

By: Davidta Brown, Senior Staff Editor – In 21st century medicine, pharmaceuticals have come to include compounds derived through novel and complex methods. Some of the most recent innovations have been in the form of biologics, therapeutic compounds produced through biological processes.1 Biologics are derived from living cell lines which may be bacterial, yeast, animal,…

Featured / In the News / Politics

The Status of Surveillance of ...

By: Sabrina Ahmed, PharmD Candidate c/o 2017 – One recent stride towards combating worldwide infectious disease has been in the improved surveillance of Japanese encephalitis in Asia, predominantly in South and South-East Asia. This potentially deadly virus is transmitted to humans via mosquito bites. The Japanese encephalitis (JE) virus is the leading cause of encephalitis…

Featured / Professional Advice / Opinions

The Importance of Organ Donati...

By: James Schurr, PharmD Candidate c/o 2014 and Jennifer Miao, PharmD Candidate c/o 2014 With very special thanks to Jessica Melore and Jennifer McDermott, PharmD, BCPS of NewYork-Presbyterian Hospital – Jessica Melore was 16 years old, a senior in high school, and co-captain of the tennis team when her life took a drastic turn. While…

Featured / In the News / Politics

A Brave New World for Lipid Ma...

By: Amrita Singh, PharmD Candidate c/o 2015 – Last November, the American College of Cardiology and the American Heart Association released new lipid guidelines, which will transform the way we manage our patients with hyperlipidemia. Earlier, lipid management was based on the ATP-III guidelines, which emphasized the use of several lipid-lowering medications to reach target…

Clinical / Featured

Psychiatric Prescriptions in t...

By: Davidta Brown, Senior Staff Editor – In August 2013, the results of a yearlong safety study were published in the Journal of American Medical Association (JAMA) Psychiatry.1 The study, which followed the health status of about 43,000 youths aged 6 to 24, confirmed and built upon a previously noted trend in adults: that the…

Featured / Professional Advice / Opinions

To Defend the People...

By: Davidta Brown, Senior Staff Editor – As the world’s largest market for pharmaceuticals, the United States receives many medications manufactured abroad.1 Patients, physicians, and pharmacists defer the responsibility of ensuring the quality of these imported drugs to the FDA, but it only takes one report of deceit in the pharmaceutical industry for this trust…

Clinical / Featured

Long Term PPI Use Heightens Co...

By: Tamara Yunusova, Senior Staff Editor – Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the treatment and prophylaxis of conditions such as peptic ulcer diseases, H. Pylori infection, Zollinger-Ellison syndrome, GERD, and NSAID gastroduodenal ulcers. Their versatility in treating a wide range of conditions, unparalleled efficacy over their Histamine-2-receptor antagonist…

Clinical / Featured

BRD4 Inhibition Eliminates Mal...

By: Richard Chung, PharmD Candidate c/o 2017 – Malignant peripheral nerve sheath tumor, otherwise known commonly as MPNST, is an aggressive sarcoma that can randomly form around peripheral nerves. Approximately 1 in 100,000 of the population is diagnosed with MPNST, with only 20-50% surviving five years after initial diagnosis.1 In addition, approximately half of the…

Featured / In the News / Politics

The Increasing Roles of Pharma...

By: Jenny Park, PharmD Candidate c/o 2015 – Medication adherence is a big part of a patient’s success in managing their health conditions. The Annals of Internal Medicine estimated that the cost of medication non-adherence may reach up to $289 billion each year.1 It is crucial for organ transplant patients to take powerful immunosuppressants to…

Featured / Professional Advice / Opinions

Pharmacy Across the Border: An...

By: Sang Hyo Kim, Staff Editor – For the brand new year, we present an interview with Sherif Guorgui, the current Vice-President of Pharmacy at the Ontario Pharmacists Association and the former 2011-2012 President of the Ontario College of Pharmacists in Canada. Mr. Guorgui graduated in 1998 from the Faculty of Pharmacy at the University…

Featured / Professional Advice / Opinions

Dr. Robert Mangione – Fr...

By: Katharine Cimmino, Editor-in-Chief and Melissa Roy, Co-Copy Editor [Graphics-Focused] – Dr. Mangione has been a prominent member here at St. John’s University both as a student and as a leader. Before becoming our dedicated Provost, Dr. Mangione was the Dean of the College of Pharmacy and Health Sciences since 1999. He joined the St.…

Clinical / Featured

New Hepatitis C Drug Receives ...

By: Ada Seldin, Staff Editor – On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C, received approval under the FDA’s priority review program. Simeprevir is an NS3/4A protease inhibitor that blocks the replication of the hepatitis C virus. Two other drugs from the same class, boceprevir and telaprevir, which were…

Featured / In the News / Politics

Say Hello to JNC8: New Hyperte...

By: Frances Trosa PharmD Candidate c/o 2015 – After much anticipation, the report from the Eighth Joint National Committee (JNC 8) has arrived! Panel members appointed to the committee have created evidence – based recommendations to assist physicians in managing hypertensive patients. A major difference between the JNC 7 report and the JNC 8 report…

Featured / In the News / Politics

The Blunt Truth...

By: Katharine Cimmino, Editor-in-Chief – Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a very popular illicit drug.1 According to the National Survey on Drug Use and Health, “In 2012, 5.4 million persons aged 12 or older used marijuana on a daily or almost daily basis in the past 12…

Featured / In the News / Politics

Direct Association of HIV and ...

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC – Human immunodeficiency virus (HIV) is a global pandemic, with approximately 35.3 million people infected in 2012. The United States currently has 1.3 million people living with HIV, with 20,000 deaths occurring every year due to acquired immune deficiency syndrome…

Clinical / Featured

Newly Approved: Macitentan (Op...

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy – The FDA approved macitentan (Opsumit®) on October 18, 2013 for the treatment of pulmonary arterial hypertension.1 Pulmonary arterial hypertension, often referred to as PAH, is a disease characterized by high blood pressure in the arteries between the heart and lungs. An increase…

Post navigation

← Older posts
Newer posts →


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post